In the acute phase of COVID-19, it has been shown that BNP level is a possible predictor for prognosis [18] and that BNP level is elevated in patients with severe COVID-19 [19], whereas another study showed that the viral infection itself has no direct impact on cardiac markers such as BNP and troponin [20]. This evidence concerns the gene NPPB and viral infectious disease.